039Hold039 – MicroVibeNews

星期一, 10月 19, 2026

Seres Therapeutics: Strong SER-155 Data, But Dilution Risk Now Warrants A 'Hold'

Seres Therapeuti…

Linde: Stock Remains A 'Hold' As I Missed The Perfect Buying Opportunity

Linde: Stock Rem…

Albany International Remains A 'Hold' Despite Attractive Valuation

Albany Internati…

Altria: Stalled Progress Makes It A 'Hold' (Rating Downgrade)

Altria: Stalled …

Brown & Brown: Short-Term Underperformance And Still A 'Hold'

Brown & Brow…

Capricor: Maintaining 'Hold' Rating On Randomized Phase 3 HOPE-3 Trial Win With Deramiocel

Capricor: Mainta…

Lands' End: Mixed Fundamentals And Declining FCF Suggests A 'Hold'

Lands' End:…